Epidemiological, Diagnostic and Therapeutic Aspects of Hepatocellular Carcinoma at the Regional Teaching Hospital of Ouahigouya in Burkina Faso
- 1 Department of Gastroenterology, Ouahigouya Regional Teaching Hospital, Ouahigouya, Burkina Faso
- 2 Department of Gastroenterology, Ouahigouya Regional Teaching Hospital, Ouahigouya, Burkina Faso
- 3 Department of Gastroenterology, Ouahigouya Regional Teaching Hospital, Ouahigouya, Burkina Faso
- 4 Department of Gastroenterology, Yalgado Ouedraogo Teaching Hospital, Ouagadougou, Burkina Faso
- 5 Department of Gastroenterology, Souro Sanou Teaching Hospital, Bobo-Dioulasso, Burkina Faso
- 6 Department of Gastroenterology, Ouahigouya Regional Teaching Hospital, Ouahigouya, Burkina Faso
- 7 Department of Gastroenterology, Yalgado Ouedraogo Teaching Hospital, Ouagadougou, Burkina Faso
- 8 Department of Gastroenterology, Souro Sanou Teaching Hospital, Bobo-Dioulasso, Burkina Faso
- 9 Department of Gastroenterology, Yalgado Ouedraogo Teaching Hospital, Ouagadougou, Burkina Faso
Abstract
Objective: The aim of the study was to clarify the epidemiological, diagnostic and therapeutic aspects of hepatocellular carcinoma at Regional Teaching Hospital of Ouahigouya in Burkina Faso. Patients and Methods : This study was a retrospective, single-center, descriptive study of patients with hepatocellular carcinoma hospitalized in the Hepato-Gastroenterology Department of Regional Teaching Hospital of Ouahigouya from February 22, 2014, to December 13, 2022. Diagnosis was based on the presence of hepatic nodules on liver cirrhosis on ultrasound or abdominal CT scan. An alpha-fetoprotein level ≥ 200 ng/mL was considered significant. Histological diagnosis was not possible in our practice setting. Results: Three hundred and twenty-two patients were hospitalized during the study period with a mean age of 48.07 ± 15.1 years. The sex ratio, male-female ratio, was 2.42. The reason for hospitalization was deterioration of general condition (94.1%), abdominal pain predominantly in the right hypochondrium (85.2%), abdominal distension (62.1%), jaundice (54.3%), and digestive hemorrhage (8%). Hepatomegaly predominated (76.1%), followed by ascites (71.1%), jaundice (54.3%), collateral venous circulation (25.7%), splenomegaly (21.1%), and encephalopathy (15.8%). Alpha fetoprotein was greater than 200 ng/mL in 56.9% of cases. HBs antigen was positive in 73.9% of cases, total anti-HBc antibodies in 89.1% of cases, and anti-HCV antibodies in 6.1% of cases. Ultrasound (99.3%) and abdominal CT scan (25.7%) showed more than multiple nodules in 50.4% of cases. Treatment was most often palliative, based on supportive care in 99.3% of cases. Conclusion : The diagnosis of hepatocellular carcinoma is always made at an advanced stage when the possibilities of curative treatment are exceeded. Biology and radiology were the main diagnostic criteria used, and treatment was symptomatic in almost all cases.
- World Health Organization and International Agency for Research on Cancer (2022) Cancer Today, Population Factsheet: Burkina Faso. IARC. https://gco.iarc.who.int/media/globocan/factsheets/populations/854-burkina-faso-fact-sheet.pdf
- Fartoux, L., Desbois-Mouton, C. and Rosmorduc, O. (2009) Carcinome hépatocellulaire: Épidémiologie, physiopathologie et diagnostic. EMC — Hépatologie , 7, 7-038-A-18. https://www.em-consulte.com/article/221460/carcinome-hepatocellulaire-epidemiologie-physiopat
- Nordenstedt, H., White, D.L. and El-Serag, H.B. (2010) The Changing Pattern of Epidemiology in Hepatocellular Carcinoma. Digestive and Liver Disease , 42, S206-S214. https://doi.org/10.1016/s1590-8658(10)60507-5
- Somé, E.N., Somé, O.R., Somda, S., Sawadogo, B., Ido, F., Lompo, L., Ouedraogo, H., et al . (2019) Le cancer primitif du foie à Ouagadougou, Burkina Faso: Le virus de l’hépatite B est-il toujours le joueur principal? Sciences de la Santé , 42, 33-42.
- Zakari, N., Appolinaire, S., Gilberte, K. and Rabiou, C. (2011) Carcinomes hépatocellulaires en milieu africain burkinabè: Contribution de l’échographie à propos de 58 cas. Pan African Medical Journal , 7, Article 10. https://doi.org/10.4314/pamj.v7i1.69116
- Kissi Anzouan-Kacou, H.Y., Kouamé, D.H., Fanou, D.C., Doffou, S.A. and Ndri-Yoman, T.A. (2017) Aspects cliniques et diagnostiques du carcinome hépatocellulaire en Côte d’Ivoire. Revue Internationale des Sciences Médicales , 19, 179-184.
- Bouglouga, O., Bagny, A., Lawson-Ananissoh, L., Djibril, M., Redah, D. and Agbetra, A. (2012) La prise en charge du carcinome hépatocellulaire progresse-t-elle en Afrique noire? La Revue Médicale de Madagascar , 2, 176-179. https://doi.org/10.62606/rmmao00066
- Yang, J.D., Mohamed, E.A., Aziz, A.O.A., Shousha, H.I., Hashem, M.B., Nabeel, M.M., et al . (2017) Characteristics, Management, and Outcomes of Patients with Hepatocellular Carcinoma in Africa: A Multicountry Observational Study from the Africa Liver Cancer Consortium. The Lancet Gastroenterology & Hepatology , 2, 103-111. https://doi.org/10.1016/s2468-1253(16)30161-3
- Harir, N., Zeggai, S., Tou, A. and Yekoru, D. (2016) Carcinome hépatocellulaire dans l’Ouest Algérien: Profil épidémiologiques et clinico-pathologiques. La Revue Médic ale de Madagascar , 6, 681-685. https://doi.org/10.62606/rmmao00178
- Mahassadi, K.A., Attia, K.A., Bathaix, Y.F., Kissi, H.Y., Assohoun, K.T. and Ndri-Yoman, T. (2005) Manifestations et facteurs cliniques prédictifs du carcinome hépatocellulaire à Abidjan (Côte d’Ivoire): Étude rétrospective de 89 cas. Médecine d ’ Afrique Noire , 52, 601-608.